GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | -95.3% | 5,005 | -95.9% | 0.00% | -95.8% |
| Q3 2020 | $4,613,000 | -26.9% | 123,192 | -20.7% | 0.02% | -35.1% |
| Q2 2020 | $6,307,000 | -7.1% | 155,394 | -13.7% | 0.04% | -22.9% |
| Q1 2020 | $6,792,000 | -21.1% | 179,984 | -2.1% | 0.05% | -2.0% |
| Q4 2019 | $8,612,000 | +7.1% | 183,802 | -2.7% | 0.05% | +4.3% |
| Q3 2019 | $8,040,000 | -5.8% | 188,957 | -11.6% | 0.05% | -7.8% |
| Q2 2019 | $8,537,000 | -11.8% | 213,866 | -7.9% | 0.05% | -15.0% |
| Q1 2019 | $9,683,000 | +212.2% | 232,295 | +184.2% | 0.06% | +160.9% |
| Q4 2018 | $3,102,000 | -53.7% | 81,750 | -51.1% | 0.02% | -43.9% |
| Q3 2018 | $6,700,000 | -4.7% | 167,279 | -4.4% | 0.04% | -6.8% |
| Q2 2018 | $7,031,000 | -1.8% | 174,929 | -4.8% | 0.04% | -6.4% |
| Q1 2018 | $7,162,000 | +114.0% | 183,789 | +94.0% | 0.05% | +135.0% |
| Q4 2017 | $3,346,000 | -34.6% | 94,740 | -25.1% | 0.02% | -37.5% |
| Q3 2017 | $5,119,000 | +32.4% | 126,490 | +40.0% | 0.03% | +18.5% |
| Q2 2017 | $3,865,000 | +11.2% | 90,380 | +9.1% | 0.03% | +12.5% |
| Q1 2017 | $3,477,000 | +19.8% | 82,810 | +9.4% | 0.02% | +14.3% |
| Q4 2016 | $2,903,000 | -35.5% | 75,720 | -27.7% | 0.02% | -36.4% |
| Q3 2016 | $4,499,000 | -8.8% | 104,760 | -8.4% | 0.03% | -10.8% |
| Q2 2016 | $4,935,000 | +0.1% | 114,420 | -6.3% | 0.04% | 0.0% |
| Q1 2016 | $4,928,000 | -3.6% | 122,080 | -4.1% | 0.04% | -11.9% |
| Q4 2015 | $5,110,000 | +6.2% | 127,290 | +1.0% | 0.04% | +10.5% |
| Q3 2015 | $4,813,000 | -5.4% | 125,970 | +2.6% | 0.04% | +8.6% |
| Q2 2015 | $5,090,000 | +6.0% | 122,835 | +17.4% | 0.04% | +2.9% |
| Q1 2015 | $4,803,000 | +8.5% | 104,620 | +0.7% | 0.03% | +13.3% |
| Q4 2014 | $4,426,000 | +1.7% | 103,905 | +9.4% | 0.03% | +15.4% |
| Q3 2014 | $4,353,000 | +0.4% | 94,935 | +16.9% | 0.03% | +4.0% |
| Q2 2014 | $4,337,000 | +19.7% | 81,225 | +19.4% | 0.02% | +19.0% |
| Q1 2014 | $3,623,000 | -1.9% | 68,005 | -1.7% | 0.02% | -8.7% |
| Q4 2013 | $3,694,000 | +0.4% | 69,185 | -5.7% | 0.02% | 0.0% |
| Q3 2013 | $3,680,000 | – | 73,355 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |